Ergebnis der Suchanfrage nach Gesundheit
Newsrooms
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
Grünenthal strengthens its Genetic Medicine Capabilities and joins the Cluster for Nucleic Acid Therapeutics Munich
Aachen, Germany (ots) - Grünenthal announced today that the company has joined the Cluster for Nucleic Acid Therapeutics Munich (CNATM), a Munich-centred innovation network that brings together leading universities, research institutions, biotech companies and industry partners to accelerate next-generation nucleic ...
mehrGrünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy
Aachen (ots) - Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD). Tegacorat, a non-steroidal Selective Glucocorticoid ...
mehrGrünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist
Aachen (ots) - - The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain. - In a Phase I trial, the investigational compound was demonstrated to be safe and well tolerated. - A Phase II trial will commence later this year. Grünenthal announced today that the ...
mehrThe Virchow Prize 2026 Awarded for Pioneering Work on Ebola, Advancing Global Epidemic Preparedness and Fostering Global Solidarity
mehrLTS Lohmann Therapie-Systeme AG
LTS Expands CDMO Portfolio with Ophthalmic Drug Delivery Solutions
Andernach (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company specializing in advanced drug delivery systems, today announced the expansion of its service portfolio to include CDMO services for ophthalmic drug delivery solutions, with manufacturing capacities located in the United States at LTS’ Lakewood, New Jersey facility. The new offering focuses initially on product ...
mehr
VITUS Privatklinik Prof. Dr. Stehling GmbH
First Clinical Analysis of Electrochemotherapy in Prostate Cancer Shows 93% Response
OFFENBACH, Germany (ots) - Vitus Privatklinik reports the first and largest clinical cohort of electrochemotherapy in prostate cancer. Vitus Privatklinik published the first clinical analysis of electrochemotherapy in prostate cancer, involving 144 patients treated between 2017 and 2024. The report is the largest dataset to date on this treatment. Radical prostatectomy ...
mehrFIBO 2026: AI Drives the Longevity & Health Boom
Cologne (ots) - FIBO 2026, the world’s leading trade show for fitness, wellness, and health, marks a strategic shift in the industry toward data-driven health and longevity models. Where traditional strength training once dominated, digital applications, connected systems, and AI-powered analytics are now shaping market development. FIBO is positioning itself as an international platform and catalyst for a new ...
mehr100,000 Participants Screened for Early-Stage Type 1 Diabetes in the EDENT1FI Project
EDENT1FI (“European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception”), a research project led by Prof. Anette-Gabriele Ziegler from Helmholtz Munich and Prof. Chantal Mathieu from the KU Leuven, has reached an important milestone toward its goal, having screened 100,000 of the more than 200,000 children and adolescents ...
mehr- 5
PM: DHL Group stärkt Logistik für das weltweite Gesundheitswesen durch Ausbau des Kühlkettennetzwerks in der Luftfracht / PR: DHL Group Expands Airfreight Cold Chain Network to Advance Global Health Logistics
2 Dokumentemehr Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030
Suresnes, France (ots/PRNewswire) - - Servier reported Group revenues of €6.9 billion for 2024/25, up 16.2% from 2023/24. - Growth over the financial year was driven by increased sales in oncology, particularly in the United States. - Several partnership agreements in oncology and neurology strengthen the Group's R&D portfolio in rare diseases. - Achieving 2025 ...
mehrSharjah Government Media Bureau
Sharjah Achieves Historic WHO Age-Friendly Status
SHARJAH, UAE (ots) - The Emirate of Sharjah, UAE, has reached a new global milestone by obtaining "Advanced Affiliate" membership in the World Health Organization’s (WHO) Global Network for Age-Friendly Cities and Communities. This makes Sharjah the first Arab city to achieve this prestigious status. This achievement underscores the emirate's deep commitment to enhancing the well-being of its senior residents and ...
mehr
30 Years of European Spas: Nature, Natural Remedies and Climate Health as Europe’s Unique Strength
mehrHealth is a Political Choice: Global Leaders Call for Shared Responsibility at the World Health Summit, Gallup and GPMB Release Landmark Reports on Emotional Wellbeing and Pandemic Preparedness
mehrGermans would value more trustworthy online health information
Gütersloh (ots) - Most people these days look online for answers to questions on health. However, many have doubts on the integrity and quality of the information provided by social media platforms and AI chatbots. The Bertelsmann Stiftung would like to contribute to promoting reliable sources and increasing confidence in digital information on health by means of its ...
mehrIEVA (Independent European Vape Alliance)
WHO must embrace harm reduction at COP11 to truly drive down global smoking rates
Brussels (ots) - As the 11th Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) approaches (17–22 November 2025, Geneva), the Independent European Vape Alliance (IEVA) calls on the World Health Organization (WHO) and its member states to finally place harm reduction at the centre of the global tobacco control debate. IEVA ...
mehrFAMAR Group: Dr. Riku Rautsola Appointed New CEO
Athens, Greece (ots/PRNewswire) - After 16 years with FAMAR, including the last 4 years as CEO, Konstantinos Rengis decided to step down from his role for personal reasons, effective September 29, 2025. Kostas is widely recognized for his customer-centric approach, deep knowledge of our industry, and his solution-oriented mindset. During his tenure, he played a pivotal role in successfully guiding the company through ...
mehrPM: DHL übernimmt SDS Rx und stärkt damit seine Kompetenzen im Bereich Life Sciences und Healthcare / PR: DHL Agrees to Acquire SDS Rx Expanding Its Life Sciences and Healthcare Capabilities
mehr
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Suresnes, France (ots/PRNewswire) - - Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company - KER-0193, a novel, orally bioavailable small molecule, was granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA - Acquisition ...
mehrHealth in the fast lane: How modern car seats protect our backs
Bremervörde (Germany) (ots) - From autonomous driving to advanced safety technologies – the innovations presented at the IAA Mobility captivate car enthusiasts. However, one key comfort factor is often overlooked: the car seat. To meet the demand for ergonomic design, the production has become increasinglycomplex – up to 12 percent of a car’s development costs are attributable to the seat. “But not every seat ...
mehr- 2
New Endoscopy Technology Enables Early Detection of Esophageal Cancer
mehr Therapeutic Vaccine for Chronic Hepatitis B Enters First Clinical Trial in Patients
mehrCroma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast
Leobendorf, Austria (ots/PRNewswire) - Saypha® injectables to launch in the U.S. under the Obagi Medical brand, expanding global reach of Croma's science-driven aesthetic solutions Croma-Pharma GmbH, a global leader in minimally invasive aesthetic medicine, today announced the acquisition of Novaestiq Corp. by Waldencast plc (Nasdaq: WALD). Novaestiq, a joint venture ...
mehrTherVacB: Advance Curative Strategy for Chronic Hepatitis B
mehr
Cancer Cachexia: Liver Identified as Driver of Body Wasting
Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, which further weakens the body. This wasting syndrome, known as cachexia, affects around half of all cancer patients. It is a major cause of therapy resistance, complications, and increased mortality. ...
mehrABDA - Bundesvereinigung Deutscher Apothekerverbände e. V.
Germany’s pharmacies under pressure: Statistical Yearbook 2025 now available
Berlin (ots) - ABDA – Federal Union of German Associations of Pharmacists has released the Statistical Yearbook “German Pharmacies: Figures, Data, Facts 2025”. The publication offers a comprehensive overview of the latest trends in the pharmaceutical and healthcare sectors in Germany and beyond. It shows that the number of pharmacies has decreased again. At the ...
mehr- 2
New Label-Free Imaging Tracks Cancer Treatment in Single Cells
mehr Axolt Launches Brain Supplement to Combat Post-Pandemic Burnout Crisis
mehrHagleitner Hygiene International GmbH
Global Hygiene Expert Pittet: Hand Hygiene Saves 5 to 8 Million Lives Each Year
mehrNew Microscope Brings Glowing Cells into Focus
mehr